SashidharVarmaSagiMDMRCP(UK) FACG

Inflammatory Bowel Disease

Consultant Gastroenterologist

Dr. Sagi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Indiana University School of MedicineFellowship, Gastroenterology, 2010 - 2013
University of Texas Medical Branch HospitalsResidency, Internal Medicine, 2007 - 2010
Rangaraya Medical College NTRClass of 1998

PubMed

54 citations
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.
Joseph Meserve, Satimai Aniwan, Jenna L. Koliani-Pace, Preeti Shashi, A Weiss
Clinical Gastroenterology and Hepatology. 2019-07-01
137 citations
Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach
Monika Fischer, Brian Sipe, Yao Wen Cheng, Emmalee Phelps, Nicholas Rogers
Gut Microbes. 2017-01-17
48 citations
Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection
Yao Wen Cheng, Emmalee Phelps, Sara Nemes, Nicholas Rogers, Sashidhar Sagi
Clinical Gastroenterology and Hepatology. 2020-09-01

Journal Articles

Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Leah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Gursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature

Why Yearly Vision Exams Are *SO* Important if You Have Crohn’sFebruary 11th, 2020